scispace - formally typeset
Search or ask a question
Institution

Stony Brook University

EducationStony Brook, New York, United States
About: Stony Brook University is a education organization based out in Stony Brook, New York, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 32534 authors who have published 68218 publications receiving 3035131 citations. The organization is also known as: State University of New York at Stony Brook & SUNY Stony Brook.


Papers
More filters
Journal ArticleDOI
TL;DR: In HIV-infected patients with limited treatment options, raltegravir plus optimization background therapy provided better viral suppression than optimized background therapy alone for at least 48 weeks.
Abstract: Results In the combined studies, 699 of 703 randomized patients (462 and 237 in the raltegravir and placebo groups, respectively) received the study drug. Seventeen of the 699 patients (2.4%) discontinued the study before week 16. Discontinuation was related to the study treatment in 13 of these 17 patients: 7 of the 462 raltegravir recipients (1.5%) and 6 of the 237 placebo recipients (2.5%). The results of the two studies were consistent. At week 16, counting noncompletion as treatment failure, 355 of 458 raltegravir recipients (77.5%) had HIV-1 RNA levels below 400 copies per milliliter, as compared with 99 of 236 placebo recipients (41.9%, P<0.001). Suppression of HIV-1 RNA to a level below 50 copies per milliliter was achieved at week 16 in 61.8% of the raltegravir recipients, as compared with 34.7% of placebo recipients, and at week 48 in 62.1% as compared with 32.9% (P<0.001 for both comparisons). Without adjustment for the length of follow-up, cancers were detect ed in 3.5% of raltegravir recipients and in 1.7% of placebo recipients. The overall frequencies of drug-related adverse events were similar in the raltegravir and placebo groups. Conclusions In HIV-infected patients with limited treatment options, raltegravir plus optimized background therapy provided better viral suppression than optimized background therapy alone for at least 48 weeks. (ClinicalTrials.gov numbers, NCT00293267 and NCT00293254.)

680 citations

Journal ArticleDOI
TL;DR: Several new opioids have been developed that modulate μ-receptor activity by selectively engaging intracellular pathways associated with analgesia and not those associated with adverse events, creating a wider therapeutic window than unselective conventional opioids.
Abstract: This review provides an overview of the clinical issue of poorly controlled postoperative pain and therapeutic approaches that may help to address this common unresolved health-care challenge. Postoperative pain is not adequately managed in greater than 80% of patients in the US, although rates vary depending on such factors as type of surgery performed, analgesic/anesthetic intervention used, and time elapsed after surgery. Poorly controlled acute postoperative pain is associated with increased morbidity, functional and quality-of-life impairment, delayed recovery time, prolonged duration of opioid use, and higher health-care costs. In addition, the presence and intensity of acute pain during or after surgery is predictive of the development of chronic pain. More effective analgesic/anesthetic measures in the perioperative period are needed to prevent the progression to persistent pain. Although clinical findings are inconsistent, some studies of local anesthetics and nonopioid analgesics have suggested potential benefits as preventive interventions. Conventional opioids remain the standard of care for the management of acute postoperative pain; however, the risk of opioid-related adverse events can limit optimal dosing for analgesia, leading to poorly controlled acute postoperative pain. Several new opioids have been developed that modulate μ-receptor activity by selectively engaging intracellular pathways associated with analgesia and not those associated with adverse events, creating a wider therapeutic window than unselective conventional opioids. In clinical studies, oliceridine (TRV130), a novel μ-receptor G-protein pathway-selective modulator, produced rapid postoperative analgesia with reduced prevalence of adverse events versus morphine.

678 citations

Journal ArticleDOI
Y. Fukuda1, T. Hayakawa1, E. Ichihara1, Kunio Inoue1, K. Ishihara1, H. Ishino1, Yoshitaka Itow1, Takaaki Kajita1, J. Kameda1, S. Kasuga1, K. Kobayashi1, Yohei Kobayashi1, Yusuke Koshio1, K. Martens1, M. Miura1, Masayuki Nakahata1, S. Nakayama1, A. Okada1, M. Oketa1, Ko Okumura1, M. Ota1, N. Sakurai1, Masato Shiozawa1, Yasunari Suzuki1, Y. Takeuchi1, Y. Totsuka1, Shinya Yamada1, M. Earl2, Alec Habig2, J. T. Hong2, E. Kearns2, S. B. Kim3, S. B. Kim2, M. Masuzawa2, M. D. Messier2, Kate Scholberg2, J. L. Stone2, L. R. Sulak2, C. W. Walter2, M. Goldhaber4, T. Barszczak5, W. Gajewski5, P. G. Halverson5, J. Hsu5, W. R. Kropp5, L. R. Price5, Frederick Reines5, H. W. Sobel5, Mark R. Vagins5, K. S. Ganezer6, W. E. Keig6, R. W. Ellsworth7, S. Tasaka8, J. W. Flanagan9, A. Kibayashi9, John G. Learned9, S. Matsuno9, V. J. Stenger9, D. Takemori9, T. Ishii, Junichi Kanzaki, T. Kobayashi, K. Nakamura, K. Nishikawa, Yuichi Oyama, A. Sakai, Makoto Sakuda, Osamu Sasaki, S. Echigo10, M. Kohama10, A. T. Suzuki10, Todd Haines5, Todd Haines11, E. Blaufuss12, R. Sanford12, R. Svoboda12, M. L. Chen13, Z. Conner14, Z. Conner13, J. A. Goodman13, G. W. Sullivan13, Masaki Mori1, Masaki Mori15, J. Hill16, C. K. Jung16, C. Mauger16, C. McGrew16, E. Sharkey16, B. Viren16, C. Yanagisawa16, W. Doki17, T. Ishizuka17, T. Ishizuka18, Y. Kitaguchi17, H. Koga17, Kazumasa Miyano17, H. Okazawa17, C. Saji17, M. Takahata17, A. Kusano19, Y. Nagashima19, M. Takita19, T. Yamaguchi19, Minoru Yoshida19, M. Etoh20, K. Fujita20, Akira Hasegawa20, Takehisa Hasegawa20, S. Hatakeyama20, T. Iwamoto20, T. Kinebuchi20, M. Koga20, T. Maruyama20, Hiroshi Ogawa20, A. Suzuki20, F. Tsushima20, Masatoshi Koshiba1, M. Nemoto21, Kyoshi Nishijima21, T. Futagami22, Y. Hayato22, Y. Kanaya22, K. Kaneyuki22, Y. Watanabe22, D. Kielczewska23, D. Kielczewska5, R. A. Doyle24, J. S. George24, A. L. Stachyra24, L. Wai24, J. Wilkes24, K. K. Young24 
TL;DR: The first results of the solar neutrino flux measurement from Super-Kamiokande are presented in this article, where the results are obtained from data taken between 31 May 1996, and 23 June 1997.
Abstract: The first results of the solar neutrino flux measurement from Super-Kamiokande are presented. The results shown here are obtained from data taken between 31 May 1996, and 23 June 1997. Using our measurement of recoil electrons with energies above 6.5 MeV, we infer the total flux of ${}^{8}\mathrm{B}$ solar neutrinos to be $2.42\ifmmode\pm\else\textpm\fi{}0.06(\mathrm{stat}{)}_{\ensuremath{-}0.07}^{+0.10}(\mathrm{syst})\ifmmode\times\else\texttimes\fi{}{10}^{6}\mathrm{cm}{}^{\ensuremath{-}2}{\mathrm{s}}^{\ensuremath{-}1}$. This result is consistent with the Kamiokande measurement and is 36% of the flux predicted by the BP95 solar model. The flux is also measured in 1.5 month subsets and shown to be consistent with a constant rate.

677 citations

Journal Article
TL;DR: In this article, the authors used oligonucleotide-based DNA microarrays to analyze transcriptional changes resulting from constitutive Ras signaling and found that Ras signaling leads to a significant induction of Interleukin-8 (IL-8) mRNA, which is accompanied by a corresponding increase in protein levels.
Abstract: 1749 Ras proteins are important regulators of cell proliferation and their constitutive activation is a key event in cancer development. To discover novel effector pathways that might contribute to the oncogenic properties of Ras, we used oligonucleotide-based DNA microarrays to analyze transcriptional changes resulting from constitutive Ras signaling. We performed the expression analyses with HeLa stable cell lines expressing activated RasG12→V transgenes under a tetracycline responsive promoter (Tet-Off™ Expression System). This system not only mediates tight on/off regulation of gene expression; it also permits the titration of protein levels on a single cell basis allowing the study of dose dependent aspects of gene activity. Ras signaling leads to a significant induction of Interleukin-8 (IL-8) mRNA, which is accompanied by a corresponding increase in protein levels. IL-8 is a chemotactic factor for leukocytes and closely associated with the initiation of an acute inflammatory response. Analysis of signal transduction pathways that link Ras to IL-8 up-regulation suggests a direct effect of Ras on the IL-8 promoter, mediated by the synergistic activation of both MAPK-cascades and the PI3K > NFκB pathway. In addition, the Ras-induced accumulation of IL-8 protein is dependent on the activation of p38 MAP-kinase through a post-transcriptional mechanism involving an increase in IL-8 mRNA stability. Investigation of the functional importance of IL-8 in the context of tumorigenesis shows that IL-8 plays a decisive role in RasV12-mediated acceleration of tumor growth in a nude mouse xenograft model. Ablation of IL-8 function is accompanied by a significant reduction in tumor size. This effect is not due to decreased cell proliferation rates, since we observe no change in the mitogenic index of tumors after inhibition of IL-8. However, tumors devoid of functional IL-8 show a marked reduction in vascularization accompanied by vast tissue necrosis. These observations can be correlated with an IL-8-mediated initiation of an early inflammatory reaction in developing neoplasms that triggers tumor vascularization. In addition, IL-8 may act directly to support angiogenesis by promoting endothelial cell proliferation and migration. These results provide a novel mechanism by which tumor cells harboring oncogenic Ras can appropriate inflammatory mediators to recruit immune cells to the tumor site and facilitate neo-angiogenesis, thus setting the stage for subsequent progression to malignancy.

675 citations

Journal ArticleDOI
TL;DR: In this article, the positive affective correlates of secure attachment in infancy and the relation between secure attachment and competence in the peer group at age 3 1/2 years were assessed.
Abstract: 2 studies were undertaken to assess the positive affective correlates of secure attachment in infancy and to assess the relation between secure attachment in infancy and competence in the peer group at age 3 1/2 years. In study 1, smiling and smiling combined with vocalizing and/or showing toys distinguished securely from anxiously attached infants during free play at age 18 months. Rated quality of affective sharing distinguished securely from anxiously attached infants during free play at 18 months and 24 months. Thus, secure attachment involves more than the absence of negative or maladaptive behavior directed toward a caregiver. Study 2 assessed cross-age, cross-situational, and cross-behavioral consistency in quality of social adaptation. Quality of infant-mother attachment relationships at age 15 months was related to Q-sort assessments of personal and interpersonal competence in the preschool play-group at age 3 1/2 years. The results contribute to the validation of attachment as an important developmental construct. They also suggest that age appropriate assessment of developmental social competence constructs can be a useful alternative to the study of homotypic behavioral continuity.

675 citations


Authors

Showing all 32829 results

NameH-indexPapersCitations
Zhong Lin Wang2452529259003
Dennis W. Dickson1911243148488
Hyun-Chul Kim1764076183227
David Baker1731226109377
J. N. Butler1722525175561
Roderick T. Bronson169679107702
Nora D. Volkow165958107463
Jovan Milosevic1521433106802
Thomas E. Starzl150162591704
Paolo Boffetta148145593876
Jacques Banchereau14363499261
Larry R. Squire14347285306
John D. E. Gabrieli14248068254
Alexander Milov142114393374
Meenakshi Narain1421805147741
Network Information
Related Institutions (5)
University of Washington
305.5K papers, 17.7M citations

97% related

Stanford University
320.3K papers, 21.8M citations

96% related

Columbia University
224K papers, 12.8M citations

96% related

University of California, Los Angeles
282.4K papers, 15.7M citations

96% related

University of Pennsylvania
257.6K papers, 14.1M citations

95% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023124
2022453
20213,609
20203,747
20193,426
20183,127